Transformingcare.

A different approach to research aimed at improving patient outcomes at the point of care. This is what ObjectiveGI is all about.

 

PHYSICIANS

Transforming Your Capabilities.

We provide the seamless integration of GI research into your practice to broaden your offerings, enhance care for your patients, and increase your support for referring physicians.

Learn More

SPONSORS

Transforming Your Research.

With premier integrated research partnerships across the country, we can offer a program supported by embedded study teams, leading to greater patient access at the point of care.

Learn More
 
 

PATIENTS

Transforming Your Outlook.

We are studying NASH and other diseases with the aim of developing new therapies to address growing problems and improve your overall health.

Learn More

Let’s work together.

We’re taking on NASH with strong research partnerships and innovative approaches that leverage a proven platform. You can be part of it.

Our Approach

Featured news

Press Release

ObjectiveGI Partnering with ARcare to Provide Advanced Diagnostics and Cutting-Edge Treatment Options for Patients

The clinically integrated research platform will provide thousands of patients with chronic digestive health conditions in the ARcare network access to advanced care options. NASHVILLE, TN, September 1, 2020 – ObjectiveGI, the integrated research and technology services platform company, announced today it has partnered with ARcare, a federally qualified health care system in Arkansas, Kentucky and Mississippi, to bring advanced diagnostics ...

Blog

International NASH Day – Bringing the disease into focus

Today, June 12, marks the third annual International NASH Day. The NASH Education Program started this campaign in 2018 to raise awareness and urgency around nonalcoholic fatty liver disease (NAFLD) and its more advanced form, nonalcoholic steatohepatitis (NASH). The Global Liver Institute continues to spearhead a consortium of patient advocacy organizations, as well as medical and professional groups, to shine ...

News

Our gut microbes influence our reactions to medications, new research shows.

A number of studies have found that certain strains of bacteria within a patient’s microbiome can impact their body’s response to medication – in both positive and negative ways. Read more to learn about these discoveries.

News

Evidence in favor of blood testing shows new technology surpassing anticipated milestones.

Despite past fraudulent claims about this technology from Theranos – the now-infamous and defunct healthcare company – blood testing capabilities are fast outpacing previous predictions in the medical field. Take a look at this FierceBiotech article to learn more.